Deciphering the Dysregulated Pathways and Candidate Therapeutic Compounds for Primary Ovarian Cancer Using Whole Transcriptomics Data and Next Generation Knowledge Discovery Strategies
- DOI
- 10.1111/jcmm.71356
- Published
- 2026-09
- Container
- Journal of Cellular and Molecular Medicine
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1111/jcmm.71356,
title = {Deciphering the Dysregulated Pathways and Candidate Therapeutic Compounds for Primary Ovarian Cancer Using Whole Transcriptomics Data and Next Generation Knowledge Discovery Strategies},
author = {Peter Natesan Pushparaj and Kalamegam Gauthaman and Alaa G. Alahmadi and Reem Nabil Hassan and Hind A. Alkhatabi and Ammar AL‐Farga},
year = {2026},
journal = {Journal of Cellular and Molecular Medicine},
doi = {10.1111/jcmm.71356},
url = {https://doi.org/10.1111/jcmm.71356}
}RIS
TY - JOUR TI - Deciphering the Dysregulated Pathways and Candidate Therapeutic Compounds for Primary Ovarian Cancer Using Whole Transcriptomics Data and Next Generation Knowledge Discovery Strategies AU - Peter Natesan Pushparaj AU - Kalamegam Gauthaman AU - Alaa G. Alahmadi AU - Reem Nabil Hassan AU - Hind A. Alkhatabi AU - Ammar AL‐Farga PY - 2026 JO - Journal of Cellular and Molecular Medicine DO - 10.1111/jcmm.71356 UR - https://doi.org/10.1111/jcmm.71356 ER -
APA
Pushparaj, P. N., Gauthaman, K., Alahmadi, A. G., Hassan, R. N., Alkhatabi, H. A., & AL‐Farga, A. (2026). Deciphering the Dysregulated Pathways and Candidate Therapeutic Compounds for Primary Ovarian Cancer Using Whole Transcriptomics Data and Next Generation Knowledge Discovery Strategies. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.71356
Source records
- crossref · retrieved 2026-09-25T05:48:39.248Z